Cas 474968-72-4,{4-[3-(tert-butylcarbonylamino)phenyl]thiazol-2-ylthio}-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide

474968-72-4

Post Buying Request

Basic information

Product Name: {4-[3-(tert-butylcarbonylamino)phenyl]thiazol-2-ylthio}-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide
Synonyms: {4-[3-(tert-butylcarbonylamino)phenyl]thiazol-2-ylthio}-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide
CAS NO:474968-72-4
Molecular Formula:
Molecular Weight: 591.626
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: {4-[3-(tert-butylcarbonylamino)phenyl]thiazol-2-ylthio}-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide(CAS DataBase Reference)
NIST Chemistry Reference: {4-[3-(tert-butylcarbonylamino)phenyl]thiazol-2-ylthio}-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide(474968-72-4)
EPA Substance Registry System: {4-[3-(tert-butylcarbonylamino)phenyl]thiazol-2-ylthio}-N-[1-(3,4-dichlorobenzyl)piperidin-4-yl]acetamide(474968-72-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 474968-72-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

474968-72-4 Suppliers

Recommended suppliers

474968-72-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 474968-72-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,4,9,6 and 8 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 474968-72:
(8*4)+(7*7)+(6*4)+(5*9)+(4*6)+(3*8)+(2*7)+(1*2)=214
214 % 10 = 4
So 474968-72-4 is a valid CAS Registry Number.

474968-72-4Upstream product

474968-72-4Downstream Products

474968-72-4Relevant academic research and scientific papers

NOVEL BENZYLPIPERIDINE COMPOUND

-

Page 68, (2010/02/05)

The object of the present invention is to provide a compound having a treatment effect based on a chemokine inhibitory activity, which is satisfactory as a pharmaceutical product for oral administration. The present inventors have found that the following

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 474968-72-4